Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Franco-Nevada
FNV
$42.7B
| $5.84M | ﹤0.01% |
42,812
-1,030
| -2% | -$136K |
|
|
GCTS
827
GCT Semiconductor Holding
GCTS
$172M
| $5.82M | ﹤0.01% |
570,395
-330,759
| -37% | -$3.34M |
|
|
YTPG
828
DELISTED
TPG Pace Beneficial II Corp.
YTPG
| $5.7M | ﹤0.01% |
580,253
-580,249
| -50% | -$5.71M |
|
829
Ford
F
$59.3B
| $5.66M | ﹤0.01% |
486,467
-517,563
| -52% | -$6.65M |
|
|
FITB
830
Fifth Third Bancorp
FITB
$51.3B
| $5.66M | ﹤0.01% |
172,474
-1,239,820
| -88% | -$42.3M |
|
831
Pan American Silver
PAAS
$18.6B
| $5.64M | ﹤0.01% |
345,482
+205,160
| +146% | +$3.28M |
|
|
FLD
832
Fold Holdings
FLD
$22.9M
| $5.63M | ﹤0.01% |
561,159
+409,159
| +269% | +$4.06M |
|
833
Camden Property Trust
CPT
$11.2B
| $5.62M | ﹤0.01% |
50,245
-1,077
| -2% | -$123K |
|
834
Sea Limited
SE
$65.1B
| $5.62M | ﹤0.01% |
107,941
-966,245
| -90% | -$52.1M |
|
835
Motorola Solutions
MSI
$71.5B
| $5.54M | ﹤0.01% |
21,507
-1,145,629
| -98% | -$286M |
|
836
T. Rowe Price
TROW
$25.6B
| $5.53M | ﹤0.01% |
50,675
-9,433
| -16% | -$1.07M |
|
837
Suzano
SUZ
$10.4B
| $5.51M | ﹤0.01% |
597,519
-755,573
| -56% | -$7.43M |
|
|
SGEN
838
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.45M | ﹤0.01% |
42,381
+9,515
| +29% | +$1.23M |
|
839
Gartner
IT
$10.2B
| $5.43M | ﹤0.01% |
16,147
+8,055
| +100% | +$2.6M |
|
840
Nucor
NUE
$58.5B
| $5.41M | ﹤0.01% |
41,032
-44,838
| -52% | -$6.09M |
|
841
Public Service Enterprise Group
PEG
$38.6B
| $5.41M | ﹤0.01% |
88,249
-193,173
| -69% | -$11.2M |
|
842
AvalonBay Communities
AVB
$26.8B
| $5.39M | ﹤0.01% |
33,361
-33,365
| -50% | -$5.68M |
|
843
Fortive
FTV
$17.7B
| $5.38M | ﹤0.01% |
111,168
-86,327
| -44% | -$4.18M |
|
844
Gen Digital
GEN
$16.3B
| $5.34M | ﹤0.01% |
249,335
-190,897
| -43% | -$4.22M |
|
845
NewAmsterdam Pharma
NAMS
$3.33B
| $5.33M | ﹤0.01% |
+563,119
| New | +$5.6M |
|
|
SHYF
846
DELISTED
The Shyft Group
SHYF
| $5.33M | ﹤0.01% |
214,377
+177,057
| +474% | +$4.12M |
|
847
Incyte
INCY
$24.9B
| $5.27M | ﹤0.01% |
65,578
+18,854
| +40% | +$1.44M |
|
848
Biogen
BIIB
$30.7B
| $5.26M | ﹤0.01% |
18,995
-14,327
| -43% | -$4.05M |
|
849
Arch Capital
ACGL
$34.5B
| $5.24M | ﹤0.01% |
83,520
-10,598
| -11% | -$592K |
|
850
BJs Wholesale Club
BJ
$12.6B
| $5.23M | ﹤0.01% |
79,114
-30,058
| -28% | -$2.18M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.